130 results
Page 3 of 7
8-K
EX-10.1
c3l23mz0 dj
14 Jun 21
Departure of Directors or Certain Officers
4:23pm
8-K
EX-99.1
2vnrasj652gehln1x
1 Jun 21
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
7:09am
8-K
EX-99.1
s9y0da9sysa01qmrn
25 Mar 21
Regulation FD Disclosure
12:00am
8-K
EX-10.1
zkiyj3 wuruyw5baj7z
20 May 20
Departure of Directors or Certain Officers
5:13pm
8-K
EX-2.1
vwsxezji8q n5ng
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm